Rationally Designed Pharmacogenomic Treatment Using Concurrent Capecitabine and Radiotherapy for Glioblastoma; Gene Expression Profiles Associated with Outcome

DOI: 10.1158/1078-0432.CCR-09-3151 Published May 2010

Online Impact

Volume 16, Issue 10, pp. 2890-2898

DOI

PubMed

Published By

Print ISSN

Online ISSN

History

Authors' Affiliations: ¹Division of Clinical Pharmacology, Department of Pharmacology and Toxicology, ²Department of Radiation Oncology, ³Division of Neuropathology, Department of Pathology, ⁴Division of Preventive Medicine, Department of Medicine, and ⁵Division of Neuro-oncology, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama

Corresponding Authors:
Martin R. Johnson, Department of Pharmacology and Toxicology, Comprehensive Cancer Center, University of Alabama at Birmingham, 1918 University Boulevard, McCallum 270, Birmingham, AL 35294. Phone: 205-975-8435; Fax: 205-975-5650; E-mail: Martin.Johnson{at}ccc.uab.edu or L. Burt Nabors, Department of Neurology, University of Alabama at Birmingham, 510 20th Street South, Birmingham, AL 35294. Phone: 205-934-1813; Fax: 205-975-7546; E-mail: bnabors{at}uab.edu.